Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

This proves that Eli Lilly's obesity drug Zepbound, as a GLP-1/GIP agonist ... will be able to take advantage of a 33.50% discount price of $399 per year. Analyst’s Disclosure: I/we have ...

President Trump's new Executive Order takes aim at high drug prices. Pharmaceutical stocks ... Drug manufacturing giant Eli Lilly LLY is priced high at $730 per share, but it’s a stock that ...

Ozempic and Wegovy maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

Novo Nordisk and Eli Lilly , the leaders in the highly lucrative ... Roche says Trump's drug price order threatens its $50 billion US investment plans U.S. President Donald Trump's executive ...

If Eli Lilly’s latest ad is any indication ... “Which is, literally, that we get to impact health, which is our way to impact humanity. I never understood if that’s so important, why do we have the ...

Pfizer, on the other hand, with its improving growth prospects, rising estimates, cheaper valuation, and higher dividend ...

AbbVie and Eli Lilly have left the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS ... country and they have a demonstrable impact on our ability to operate sustainably in ...

The company recently released new trial data showing its weight loss drug, Zepbound, posted stronger results than its peer’s drug Wegovy. Eli Lilly and ... reduced the price target on LLY ...